These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3975648)

  • 1. Progestin therapy in lesions of the endometrium.
    Wentz WB
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
    Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
    Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia.
    Gal D; Edman CD; Vellios F; Forney JP
    Am J Obstet Gynecol; 1983 Jun; 146(3):316-22. PubMed ID: 6859142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megestrol acetate in the management of advanced endometrial carcinoma.
    Wait RB
    Obstet Gynecol; 1973 Jan; 41(1):129-36. PubMed ID: 4682608
    [No Abstract]   [Full Text] [Related]  

  • 5. Hyperglycemia secondary to megestrol acetate for endometrial neoplasia.
    Rose PG
    Gynecol Oncol; 1996 Apr; 61(1):139-41. PubMed ID: 8626102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of advanced endometrial cancer].
    Okada H; Yamamoto T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
    Park H; Seok JM; Yoon BS; Seong SJ; Kim JY; Shim JY; Park CT
    Arch Gynecol Obstet; 2012 Feb; 285(2):473-8. PubMed ID: 21706284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
    Hoffman MS; Roberts WS; Cavanagh D; Praphat H; Solomon P; Lyman GH
    Gynecol Oncol; 1989 Oct; 35(1):75-7. PubMed ID: 2477317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
    Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
    Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
    Park JY; Lee SH; Seong SJ; Kim DY; Kim TJ; Kim JW; Kim JH; Kim YM; Kim YT; Bae DS; Nam JH
    Gynecol Oncol; 2013 Apr; 129(1):7-11. PubMed ID: 23283299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megestrol acetate: clinical experience.
    Schacter L; Rozencweig M; Canetta R; Kelley S; Nicaise C; Smaldone L
    Cancer Treat Rev; 1989 Mar; 16(1):49-63. PubMed ID: 2471590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of progestational agents in endometrial adenocarcinoma.
    Rozier JC; Underwood PB
    Obstet Gynecol; 1974 Jul; 44(1):60-4. PubMed ID: 4834800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal therapy for lesions of the endometrium.
    Gal D
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):33-6. PubMed ID: 3798126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megestrol acetate for the palliation of advanced ovarian carcinoma.
    Geisler HE
    Obstet Gynecol; 1983 Jan; 61(1):95-8. PubMed ID: 6185891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestin therapy in endometrial hyperplasia.
    Wentz WB
    Gynecol Oncol; 1974 Aug; 2(2-3):362-7. PubMed ID: 4457410
    [No Abstract]   [Full Text] [Related]  

  • 16. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
    Kline RC; Freedman RS; Jones LA; Atkinson EN
    Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
    [No Abstract]   [Full Text] [Related]  

  • 18. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives.
    Shen ZQ; Zhu HT; Lin JF
    Obstet Gynecol; 2008 Aug; 112(2 Pt 2):465-7. PubMed ID: 18669766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
    Mentrikoski MJ; Shah AA; Hanley KZ; Atkins KA
    Am J Clin Pathol; 2012 Oct; 138(4):524-34. PubMed ID: 23010707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of high-dose megestrol acetate in the treatment of ovarian adenocarcinoma.
    Geisler HE
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):20-2. PubMed ID: 3975647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.